期刊文献+

多西紫杉醇联合LFP方案治疗晚期胃癌的临床观察 被引量:3

下载PDF
导出
摘要 胃癌是我国常见的恶性肿瘤之一,早期因缺乏特异征象,就诊时大部分已属晚期,失去手术根治的机会,化疗是其主要治疗手段,但常规化疗的有效率为30%~40%,尤其是完全缓解率过低,中位生存期无明显改善。近年来新药、新方案的临床治疗逐渐形成主流。目前尚无公认的规范标准化疗方案。我科从2005年7月~2006年9月应用多西紫杉醇联合顺铂、氟尿嘧啶和亚叶酸钙联合治疗晚期胃癌取得较好疗效,现将结果报告如下。
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第24期1397-1398,1406,共3页 Chinese Journal of Clinical Oncology
  • 相关文献

参考文献10

  • 1陈智伟,廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤,2004,13(10):616-618. 被引量:176
  • 2吴芳,张弘纲.多西紫杉醇在晚期胃癌的临床应用[J].癌症进展,2007,5(3):276-281. 被引量:42
  • 3Kubota T. Theoretical basis for low-dose DDP/5-FU therapy[J]. JpnJ Cancer Chemother, 1999, 26(11): 1536--1541.
  • 4Yoshida K, Tanabe K, Ueno H, et al. Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study[J]. Castric Cancer, 2003, 6 (Suppl 1): 82-89.
  • 5KinoshitaJ, Kitamura K, Kabashima A, et al. Clinical significance of vascular endothelial growth factor-C(VEGF--C) in breast cancer[J]. Breast Cancer Res Treat, 2001, 66(2): 159-164.
  • 6Bang YJ ,Kang WK, Kang YK, et al. Docetaxel 75mg/m^2 is active and well tolerated in patients with metastatic or recurrent gastric cander: a phase II trial[]].JpnJ Clin Oncol, 2002, 32(7): 248-254.
  • 7Furue H, Taguchi T. A late phase Ⅱ clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer (Abstr)[J]. Ann Oncol, 1998, 9(Suppl 4): 233.
  • 8Ridwelski K, Gebauer T, Fahlke J, et al. Docetaxel and cisplatin combination therapy for advanced gastric cancer: results of two phase II studies(Abstr)[J]. Proc Am Soc Oncol, 2001, 20: 165.
  • 9Ajani JA, Fodor M_B, Tjulandin SA, et al. Phase Ⅱ mulfi-institu-donal randomized trial of docetaxel plus cisplatin with orwithout fluorouracil in padents with undreated, advanced gastric, or gastroesophageal adenocarcinoma[J]. J Clin Oncol, 2005, 23 (24): 5660--5667.
  • 10Ajani JA, Van Cutsem E, Moiseyenko V, et al. Docetaxel,cisplatin,5-fluorouracil compared to cisplatin and 5-fluorouracil for chemothempy--naive patients with metastatic or locally recurrent, unresectable gastric carcinoma: interim results of a randomized phase Ⅲ trial(V325) (abstr) [J]. Proc Am Soc Clin Oncol, 2003, 22: 249.

二级参考文献38

  • 1WHO handbook for reporting results of cancer treatment [M].Geneva (Switzerland):World Health Organization,1979.
  • 2Duffaud F,Therasse P.New guidelines to evaluate the response to treatment in solid tumors[J].Bull Cancer,2000,87(12):869-870.
  • 3James K,Eisenhauer E,Christian M,et al.Measuring response in solid tumors:unidimensional versus bidimensional measurement[J].J Natl Cancer Inst,1999,91(6):523-528.
  • 4Mazumdar M,Smith A,Schwartz LH.A statistical simulation study finds discordance between WHO criteria and RECIST guideline[J].J Clin Epidemiol,2004,57(4):358-365.
  • 5Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors [J].J Natl Cancer Inst,2000,92(3):179-181.
  • 6Werner-Wasik M,Xiao Y,Pequignot E,et al.Assessment of lung cancer response after nonoperative therapy:tumor diameter,bidimensional product,and volume.A serial CT sean-based study[J].Int J Radiat Oncol Biol Phys,2001,51(1):56-61.
  • 7Prasad SR,Saini S,Sumner JE,et al.Radiological measurement of breast cancer metastases to lung and liver:comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines [J].J Comput Assist Tomogr,2003,27(3):380-384.
  • 8Trillet-Lenoir V,Freyer G,Kaemmerlen P,et al.Assessment of tumour response to chemotherapy for metastatic coloreetal cancer:accuracy of the RECIST criteria[J].BrJ Radiol,2002,75(899):903-908.
  • 9[1]Sulkes A,Smyth J,Sessa C,et al.Docetaxel(Taxotere) in advanced gastric cancer:Results of a phase Ⅱ clinical trial.EORTC Early Clinical Trials Group.Br J Cancer,1994,70:380
  • 10[2]Einzig AI,Neuberg D,Remick SC,et al.Phase Ⅱ trial of docetaxel (Taxotere) in patients with adenoearcinoma of the upper gastrointestinal tract previously tmtreated with cytotoxic chemotherapy:The Eastern Cooperative Oncology Group(ECOG)resuits of protocol E1293.Med Oncol,1996,13:87

共引文献215

同被引文献31

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部